English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 847831 Online Users : 537
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
感染症與疫苗研究所
劉士任
--專利
--期刊論文
--圖書
--會議論文/會議摘要
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
國家衛生研究院 NHRI
>
感染症與疫苗研究所
>
劉士任
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
專利
[
0
/24]
期刊論文
[
110
/113]
圖書
[
1
/1]
會議論文/會議摘要
[
10
/11]
Siblings
余佳益
[
17
/17]
余冠儀
[
40
/40]
冷治湘
[
61
/89]
劉家齊
[
45
/52]
司徒惠康
[
71
/72]
吳綺容
[
84
/84]
周彥宏
[
46
/58]
宋旺洲
[
33
/34]
廖經倫
[
32
/32]
張仲明
[
2
/2]
張堯
[
44
/44]
曾凡真
[
34
/34]
曾才騰
[
9
/9]
李敏西
[
60
/64]
杜鴻運
[
50
/50]
楊采菱
[
133
/134]
潘建雄
[
18
/19]
羅秀容
[
96
/97]
胡勇誌
[
23
/23]
莊再成
[
104
/153]
蕭樑基
[
158
/161]
蘇益仁(2002-2015)
[
190
/195]
許修誌(2005-2010)
[
1
/1]
許素菁
[
27
/30]
謝鐸源(2006-2014)
[
20
/27]
郭書辰
[
139
/141]
陳俊宏
[
61
/62]
陳信偉
[
83
/110]
陳宜君
[
38
/38]
陳逢叡
[
40
/40]
黃明熙
[
51
/64]
黃盈綺
[
6
/6]
齊嘉鈺
[
46
/46]
McDonald LC(1998-2000)
[
12
/12]
何曼德(1997-2002)
[
38
/39]
其他
[
177
/177]
朱清良(2005-2007)
[
4
/4]
梁蘭蘭(1998-2006)
[
6
/6]
黃崑巖(1999-2004)
[
4
/4]
Community Statistics
近3年內發表的文件:19(12.75%)
含全文筆數:121(81.21%)
文件下載次數統計
下載大於0次:121(100.00%)
下載大於100次:115(95.04%)
檔案下載總次數:67278(1.26%)
最後更新時間: 2024-11-28 09:35
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Boosting DNA vaccine power by lipid...
ADAM9 drives the immunosuppressive ...
Inhibition of ADAM9 promotes the se...
Lipid nanoparticle-encapsulated DNA...
ADAM9 drives immunosuppressive envi...
A broad-spectrum pneumococcal vacci...
Co-delivery of a trimeric spike DNA...
A TLR9 agonist synergistically enha...
TLR9 and STING agonists cooperative...
Recombinant lipidated FLIPr effecti...
Jump to a point in the index:
(Choose year)
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-50 of 149. (3 Page(s) Totally)
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2024-09-10
Boosting DNA vaccine power by lipid nanoparticles surface engineered with amphiphilic bioresorbable copolymer
Molecular Therapy Nucleic Acids. 2024 Sep 10;35(3):Article number 102261.
2024-03-14
Lipid nanoparticle-encapsulated DNA vaccine robustly induce superior immune responses to the mRNA vaccine in Syrian hamsters
Molecular Therapy Methods and Clinical Development. 2024 Mar 14;32(1):Article number 101169.
2024-03
Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy
Nature Cancer. 2024 Mar;5(3):400-419.
2024
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progression
American Journal of Cancer Research. 2024;14(4):1850-1865.
2023-12
A broad-spectrum pneumococcal vaccine induces mucosal immunity and protects against lethal Streptococcus pneumoniae challenge
Emerging Microbes and Infections. 2023 Dec;12(2):Article number 2272656.
2023-08-27
Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2
Journal of Medical Virology. 2023 Aug 27;95(8):Article number e29040.
2023-08-16
A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine
Emerging Microbes and Infections. 2023 Aug 16;12(2):Article number 2249130.
2023-08
Humoral and cellular immunity in three different types of COVID-19 vaccines against SARS-CoV-2 variants in a real-world data analysis
Journal of Microbiology, Immunology and Infection. 2023 Aug;56(4):705-717.
2023-06-02
Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types
npj Vaccines. 2023 Jun 02;8:Article number 82.
2023-05-29
TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses
International Journal of Biological Sciences. 2023 May 29;19(9):2897-2913.
2023-05-01
ADAM9 drives immunosuppressive environment for lung tumor progression
Journal of Immunology. 2023 May 01;210(Suppl. 1):Abstract number 172.08.
2023-01-23
A flexible liposomal polymer complex as a platform of specific and regulable immune regulation for individual cancer immunotherapy
Journal of Experimental and Clinical Cancer Research. 2023 Jan 23;42:Article number 29.
2022-12-02
Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies
Journal of Medical Virology. 2022 Dec 2;95:Article number e28370.
2022-11-21
Formulation of SARS-CoV-2 spike protein with CpG oligodeoxynucleotides and squalene nanoparticles modulates immunological aspects following intranasal delivery
Pharmaceutics. 2022 Nov 21;14(11):Article number 2539.
2022-06-09
Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy
Journal of Biomedical Science. 2022 Jun 9;29:Article number 37.
2022-06-03
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
npj Vaccines. 2022 Jun 03;7:Article number 60.
2022-05-02
Furin and TMPRSS2 resistant spike induces robust humoral and cellular immunity against SARS-CoV-2 lethal infection
Frontiers in Immunology. 2022 May 2;13:Article number 872047.
2022-04-28
Low-dose SARS-CoV-2 S-trimer with an emulsion adjuvant induced th1-biased protective immunity
International Journal of Molecular Sciences. 2022 Apr 28;23(9):Article number 4902.
2022-04-22
Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
JCI Insight. 2022 Apr 22;7(8):Article number e157597.
2021-10-11
Intranasal vaccination with recombinant antigen-FLIPr fusion protein alone induces long-lasting systemic antibody responses and broad T cell responses
Frontiers in Immunology. 2021 Oct 11;12:Article number 751883.
2021-10-05
A novel rapid test to detect anti-SARS-CoV-2 n protein IgG based on shear horizontal surface acoustic wave (SH-SAW)
Diagnostics. 2021 Oct 5;11(10):Article number 1838.
2021-10
Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
Journal for Immunotherapy of Cancer. 2021 Oct;9(10):Article number e002758.
2021-09-25
Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19
International Journal of Pharmaceutics. 2021 Sep 25;607:Article number 121024.
2021-09
Squalene nanoemulsion reinforces mucosal and immunological fingerprints following intravaginal delivery
Biomedicine and Pharmacotherapy. 2021 Sep;141:Article number 111799.
2021-08-11
Characterization of virus replication, pathogenesis, and cytokine responses in syrian hamsters inoculated with SARS-CoV-2
Journal of Inflammation Research. 2021 Aug 11;14:3781-3795.
2021-07-12
A novel recombinant Fc gamma receptor-targeted survivin combines with chemotherapy for efficient cancer treatment
Biomedicines. 2021 Jul 12;9(7):Article number 806.
2021-05-27
DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss
PLoS Neglected Tropical Diseases. 2021 May 27;15(5):Article number e0009374.
2021-05
Immunogenic peptide containing a b cell epitope of tumor associated antigen L6
2021-05-04(US10995126B2).
2020-10-21
A polypeptide of tumor-associated antigen L6 with intrinsic adjuvant activity enhances antitumor immunity
Vaccines. 2020 Oct 21;8(4):Article number 620.
2020-10-09
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination
Journal for ImmunoTherapy of Cancer. 2020 Oct 9;8(2):Article number e001022.
2020-04-14
Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
Journal of Biomedical Science. 2020 Apr 14;27:Article number 51.
2020-04
Liposomal TLR9 agonist combined with TLR2 agonist-fused antigen can modulate tumor microenvironment through dendritic cells
Cancers. 2020 Apr;12(4):Article number 810.
2019-11-01
包含腫瘤相關抗原L6之B細胞抗原決定位之免疫原胜肽
I675843/2019-11-01
2019-10
Domain 4 of pneumolysin from Streptococcus pneumoniae is a multifunctional domain contributing TLR4 activating and hemolytic activity
Biochemical and Biophysical Research Communications. 2019 Oct;517(4):596-602.
2019-10
ADAM9 as a target for lung cancer treatment
Annals of Oncology. 2019 Oct;30(Suppl. 5):788.
2019-10
Synthetic peptide of tumour-associated antigen L6 formulated with polymer-based adjuvant enhances anti-tumour effects in mice
Annals of Oncology. 2019 Oct;30(Suppl. 5):23.
2019-09-01
Endoplasmic reticulum-targeting sequence enhanced the cellular immunity of a tumor-associated antigen L6-based DNA vaccine
American Journal of Cancer Research. 2019 Sep 1;9(9):2028-2036.
2019-08-02
Delivery of antigen to CD8(+) dendritic cells by fusing antigen with formyl peptide receptor-like 1 inhibitor protein induces antitumor immunity
Frontiers in Immunology. 2019 Aug 2;10:Article number 1839.
2019-04-11
Immunological evaluation of a novel HLA-A2 restricted phosphopeptide of tumor associated Antigen, TRAP1, on cancer therapy
Vaccine: X. 2019 Apr 11;1:Article number 100017.
2019-01-24
Sorbitan polyester conjugates for stabilizing water-in-oil emulsions and delivering controlled release of bioactive agents
AU2016215757/2019-01-24
2019-01-08
Sorbitan polyester conjugates for stabilizing water-in-oil emulsions and delivering controlled release of bioactive agents
US10172945B2/2019-01-08
2018-12
A therapeutic vaccine targeting HPV E6/E7 with intrinsic Toll-like receptor 2 agonist activity induces antitumor immunity
American Journal of Cancer Research. 2018 Dec;8(12):2528-2537.
2018-10
Efficient uptake of recombinant lipidated survivin by antigen-presenting cells initiates antigen cross-presentation and antitumor immunity
Journal of Thoracic Oncology. 2018 Oct;13(10, Suppl.):S526.
2018-08
Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells
EMBO Reports. 2018 Aug;19(8):Article number e46182.
2018-05
Cross-presentation of lipidated and non-lipidated synthetic peptide
European Journal of Immunology. 2018 May;48(Suppl. 1):36.
2018-04-23
Efficient uptake of recombinant lipidated survivin by antigen-presenting cells initiates antigen cross-presentation and antitumor immunity
Frontiers in Immunology. 2018 Apr 23;9:Article number 822.
2018-04-18
Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery
ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
2017-11
用於穩定油包水乳液及控制釋放生物活性物質之山梨醇酐聚酯複合體
2017 2017-11-28(CN107405304A).
2017-09
用於穩定油包水乳液及控制釋放生物活性物質之山梨醇酐聚酯複合體
I598114/2017-09-11
2017-03
Recent progress in GM-CSF-based cancer immunotherapy
Immunotherapy. 2017 Mar;9(4):347-360.
Showing items 1-50 of 149. (3 Page(s) Totally)
1
2
3
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback